APO Research, Inc.

APO RESEARCH · REPORT

Peripheral Coil Embolization System

Selected research

Market Outlook & Growth Opportunities

Global Peripheral Coil Embolization System Market Outlook and Growth Opportunities 2026

Market perspective

The global Peripheral Coil Embolization System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Peripheral Coil Embolization System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Peripheral Coil Embolization System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peripheral Coil Embolization System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Peripheral Coil Embolization System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Peripheral Coil Embolization System market include Cook, Johnson & Johnson, Kaneka, Microvention, Penumbra, Stryker, Boston Scientific, Zylox-Tonbridge Medical Technology and Genesis MedTech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Peripheral Coil Embolization System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Peripheral Coil Embolization System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Peripheral Coil Embolization System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Peripheral Coil Embolization System market size, projected growth trends, production technologies, key applications, and end-use industries.

Peripheral Coil Embolization System Segment by Company

Cook

Johnson & Johnson

Kaneka

Microvention

Penumbra

Stryker

Boston Scientific

Zylox-Tonbridge Medical Technology

Genesis MedTech

Conmind

Medtronic

Peijia Medical

Shanghai Shenqi Medical Technology

Shanghai Xiaoyu Medical Technology

Suzhou Zhongtian Medical Device Technology

Beijing Taijieweiye Technology

MicroPort Scientific

Shandong Visee Medical Devices

Peripheral Coil Embolization System Segment by Type

Mechanical Release

Electromechanical Release

Peripheral Coil Embolization System Segment by Application

Arteriovenous Malformation

Arteriovenous Fistula

Other

Peripheral Coil Embolization System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Peripheral Coil Embolization System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Peripheral Coil Embolization System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Peripheral Coil Embolization System significant trends, drivers, influence factors in global and regions.

6. To analyze Peripheral Coil Embolization System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peripheral Coil Embolization System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peripheral Coil Embolization System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peripheral Coil Embolization System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Peripheral Coil Embolization System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peripheral Coil Embolization System industry.

Chapter 3: Detailed analysis of Peripheral Coil Embolization System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Peripheral Coil Embolization System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Peripheral Coil Embolization System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Peripheral Coil Embolization System Industry Trends Table 2. Peripheral Coil Embolization System Industry Drivers Table 3. Peripheral Coil Embolization System Industry Opportunities and Challenges Table 4. Peripheral Coil Embolization System Industry Restraints Table 5. Global Peripheral Coil Embolization System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Peripheral Coil Embolization System Revenue Share by Company (2021-2026) Table 7. Global Peripheral Coil Embolization System Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Peripheral Coil Embolization System Sales Volume Share by Company (2021-2026) Table 9. Global Peripheral Coil Embolization System Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Peripheral Coil Embolization System Company Ranking, (2024-2026) & (USD Million) Table 11. Global Peripheral Coil Embolization System Key Company Manufacturing Base & Headquarters Table 12. Global Peripheral Coil Embolization System Company, Product Type & Application Table 13. Global Peripheral Coil Embolization System Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Peripheral Coil Embolization System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Mechanical Release Table 18. Significant Companies of Electromechanical Release Table 19. Global Peripheral Coil Embolization System Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Peripheral Coil Embolization System Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Peripheral Coil Embolization System Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Peripheral Coil Embolization System Sales Volume Share by Type (2021-2026) Table 23. Global Peripheral Coil Embolization System Sales Volume Share by Type (2027-2032) Table 24. Global Peripheral Coil Embolization System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Peripheral Coil Embolization System Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Peripheral Coil Embolization System Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Peripheral Coil Embolization System Sales Value Share by Type (2021-2026) Table 28. Global Peripheral Coil Embolization System Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Arteriovenous Malformation Table 30. Significant Companies of Arteriovenous Fistula Table 31. Significant Companies of Other Table 32. Global Peripheral Coil Embolization System Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Peripheral Coil Embolization System Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Peripheral Coil Embolization System Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Peripheral Coil Embolization System Sales Volume Share by Application (2021-2026) Table 36. Global Peripheral Coil Embolization System Sales Volume Share by Application (2027-2032) Table 37. Global Peripheral Coil Embolization System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Peripheral Coil Embolization System Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Peripheral Coil Embolization System Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Peripheral Coil Embolization System Sales Value Share by Application (2021-2026) Table 41. Global Peripheral Coil Embolization System Sales Value Share by Application (2027-2032) Table 42. Global Peripheral Coil Embolization System Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Peripheral Coil Embolization System Sales by Region (2021-2026) & (K Units) Table 44. Global Peripheral Coil Embolization System Sales Market Share by Region (2021-2026) Table 45. Global Peripheral Coil Embolization System Sales by Region (2027-2032) & (K Units) Table 46. Global Peripheral Coil Embolization System Sales Market Share by Region (2027-2032) Table 47. Global Peripheral Coil Embolization System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Peripheral Coil Embolization System Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Peripheral Coil Embolization System Sales Value Share by Region (2021-2026) Table 50. Global Peripheral Coil Embolization System Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Peripheral Coil Embolization System Sales Value Share by Region (2027-2032) Table 52. Global Peripheral Coil Embolization System Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Peripheral Coil Embolization System Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Peripheral Coil Embolization System Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Peripheral Coil Embolization System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Peripheral Coil Embolization System Sales by Country (2021-2026) & (K Units) Table 57. Global Peripheral Coil Embolization System Sales Market Share by Country (2021-2026) Table 58. Global Peripheral Coil Embolization System Sales by Country (2027-2032) & (K Units) Table 59. Global Peripheral Coil Embolization System Sales Market Share by Country (2027-2032) Table 60. Global Peripheral Coil Embolization System Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Peripheral Coil Embolization System Sales Value Market Share by Country (2021-2026) Table 62. Global Peripheral Coil Embolization System Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Peripheral Coil Embolization System Sales Value Market Share by Country (2027-2032) Table 64. Cook Company Information Table 65. Cook Business Overview Table 66. Cook Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Cook Peripheral Coil Embolization System Product Portfolio Table 68. Cook Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Peripheral Coil Embolization System Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Kaneka Company Information Table 75. Kaneka Business Overview Table 76. Kaneka Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Kaneka Peripheral Coil Embolization System Product Portfolio Table 78. Kaneka Recent Development Table 79. Microvention Company Information Table 80. Microvention Business Overview Table 81. Microvention Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Microvention Peripheral Coil Embolization System Product Portfolio Table 83. Microvention Recent Development Table 84. Penumbra Company Information Table 85. Penumbra Business Overview Table 86. Penumbra Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Penumbra Peripheral Coil Embolization System Product Portfolio Table 88. Penumbra Recent Development Table 89. Stryker Company Information Table 90. Stryker Business Overview Table 91. Stryker Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Stryker Peripheral Coil Embolization System Product Portfolio Table 93. Stryker Recent Development Table 94. Boston Scientific Company Information Table 95. Boston Scientific Business Overview Table 96. Boston Scientific Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Boston Scientific Peripheral Coil Embolization System Product Portfolio Table 98. Boston Scientific Recent Development Table 99. Zylox-Tonbridge Medical Technology Company Information Table 100. Zylox-Tonbridge Medical Technology Business Overview Table 101. Zylox-Tonbridge Medical Technology Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Zylox-Tonbridge Medical Technology Peripheral Coil Embolization System Product Portfolio Table 103. Zylox-Tonbridge Medical Technology Recent Development Table 104. Genesis MedTech Company Information Table 105. Genesis MedTech Business Overview Table 106. Genesis MedTech Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Genesis MedTech Peripheral Coil Embolization System Product Portfolio Table 108. Genesis MedTech Recent Development Table 109. Conmind Company Information Table 110. Conmind Business Overview Table 111. Conmind Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Conmind Peripheral Coil Embolization System Product Portfolio Table 113. Conmind Recent Development Table 114. Medtronic Company Information Table 115. Medtronic Business Overview Table 116. Medtronic Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Medtronic Peripheral Coil Embolization System Product Portfolio Table 118. Medtronic Recent Development Table 119. Peijia Medical Company Information Table 120. Peijia Medical Business Overview Table 121. Peijia Medical Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Peijia Medical Peripheral Coil Embolization System Product Portfolio Table 123. Peijia Medical Recent Development Table 124. Shanghai Shenqi Medical Technology Company Information Table 125. Shanghai Shenqi Medical Technology Business Overview Table 126. Shanghai Shenqi Medical Technology Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Shanghai Shenqi Medical Technology Peripheral Coil Embolization System Product Portfolio Table 128. Shanghai Shenqi Medical Technology Recent Development Table 129. Shanghai Xiaoyu Medical Technology Company Information Table 130. Shanghai Xiaoyu Medical Technology Business Overview Table 131. Shanghai Xiaoyu Medical Technology Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Shanghai Xiaoyu Medical Technology Peripheral Coil Embolization System Product Portfolio Table 133. Shanghai Xiaoyu Medical Technology Recent Development Table 134. Suzhou Zhongtian Medical Device Technology Company Information Table 135. Suzhou Zhongtian Medical Device Technology Business Overview Table 136. Suzhou Zhongtian Medical Device Technology Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Suzhou Zhongtian Medical Device Technology Peripheral Coil Embolization System Product Portfolio Table 138. Suzhou Zhongtian Medical Device Technology Recent Development Table 139. Beijing Taijieweiye Technology Company Information Table 140. Beijing Taijieweiye Technology Business Overview Table 141. Beijing Taijieweiye Technology Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Beijing Taijieweiye Technology Peripheral Coil Embolization System Product Portfolio Table 143. Beijing Taijieweiye Technology Recent Development Table 144. MicroPort Scientific Company Information Table 145. MicroPort Scientific Business Overview Table 146. MicroPort Scientific Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. MicroPort Scientific Peripheral Coil Embolization System Product Portfolio Table 148. MicroPort Scientific Recent Development Table 149. Shandong Visee Medical Devices Company Information Table 150. Shandong Visee Medical Devices Business Overview Table 151. Shandong Visee Medical Devices Peripheral Coil Embolization System Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Shandong Visee Medical Devices Peripheral Coil Embolization System Product Portfolio Table 153. Shandong Visee Medical Devices Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Peripheral Coil Embolization System Distributors List Table 157. Peripheral Coil Embolization System Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Peripheral Coil Embolization System Product Image Figure 2. Global Peripheral Coil Embolization System Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peripheral Coil Embolization System Sales Value (2021-2032) & (US$ Million) Figure 4. Global Peripheral Coil Embolization System Sales (2021-2032) & (K Units) Figure 5. Global Peripheral Coil Embolization System Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Peripheral Coil Embolization System Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Mechanical Release Image Figure 10. Electromechanical Release Image Figure 11. Global Peripheral Coil Embolization System Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Peripheral Coil Embolization System Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Peripheral Coil Embolization System Sales Volume Share by Type (2021-2032) Figure 14. Global Peripheral Coil Embolization System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Peripheral Coil Embolization System Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Peripheral Coil Embolization System Sales Value Share by Type (2021-2032) Figure 17. Arteriovenous Malformation Image Figure 18. Arteriovenous Fistula Image Figure 19. Other Image Figure 20. Global Peripheral Coil Embolization System Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Peripheral Coil Embolization System Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Peripheral Coil Embolization System Sales Volume Share by Application (2021-2032) Figure 23. Global Peripheral Coil Embolization System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Peripheral Coil Embolization System Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Peripheral Coil Embolization System Sales Value Share by Application (2021-2032) Figure 26. Global Peripheral Coil Embolization System Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Peripheral Coil Embolization System Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Peripheral Coil Embolization System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Peripheral Coil Embolization System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Peripheral Coil Embolization System Sales Value (2021-2032) & (US$ Million) Figure 31. North America Peripheral Coil Embolization System Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Peripheral Coil Embolization System Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Peripheral Coil Embolization System Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Peripheral Coil Embolization System Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Peripheral Coil Embolization System Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Peripheral Coil Embolization System Sales Value (2021-2032) & (US$ Million) Figure 37. South America Peripheral Coil Embolization System Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Peripheral Coil Embolization System Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Peripheral Coil Embolization System Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Peripheral Coil Embolization System Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Peripheral Coil Embolization System Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Mechanical Release
  • Electromechanical Release
Applications
  • Arteriovenous Malformation
  • Arteriovenous Fistula
  • Other
Companies covered
  • Cook
  • Johnson & Johnson
  • Kaneka
  • Microvention
  • Penumbra
  • Stryker
  • Boston Scientific
  • Zylox-Tonbridge Medical Technology
  • Genesis MedTech
  • Conmind
  • Medtronic
  • Peijia Medical
  • Shanghai Shenqi Medical Technology
  • Shanghai Xiaoyu Medical Technology
  • Suzhou Zhongtian Medical Device Technology
  • Beijing Taijieweiye Technology
  • MicroPort Scientific
  • Shandong Visee Medical Devices

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peripheral Coil Embolization System Sales Value (2021-2032)
  4. 1.2.2 Global Peripheral Coil Embolization System Sales Volume (2021-2032)
  5. 1.2.3 Global Peripheral Coil Embolization System Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Peripheral Coil Embolization System Market Dynamics
  1. 2.1 Peripheral Coil Embolization System Industry Trends
  2. 2.2 Peripheral Coil Embolization System Industry Drivers
  3. 2.3 Peripheral Coil Embolization System Industry Opportunities and Challenges
  4. 2.4 Peripheral Coil Embolization System Industry Restraints
3 Peripheral Coil Embolization System Market by Company
  1. 3.1 Global Peripheral Coil Embolization System Company Revenue Ranking in 2025
  2. 3.2 Global Peripheral Coil Embolization System Revenue by Company (2021-2026)
  3. 3.3 Global Peripheral Coil Embolization System Sales Volume by Company (2021-2026)
  4. 3.4 Global Peripheral Coil Embolization System Average Price by Company (2021-2026)
  5. 3.5 Global Peripheral Coil Embolization System Company Ranking (2024-2026)
  6. 3.6 Global Peripheral Coil Embolization System Company Manufacturing Base and Headquarters
  7. 3.7 Global Peripheral Coil Embolization System Company Product Type and Application
  8. 3.8 Global Peripheral Coil Embolization System Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Peripheral Coil Embolization System Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Peripheral Coil Embolization System Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Peripheral Coil Embolization System Market by Type
  1. 4.1 Peripheral Coil Embolization System Type Introduction
  2. 4.1.1 Mechanical Release
  3. 4.1.2 Electromechanical Release
  4. 4.2 Global Peripheral Coil Embolization System Sales Volume by Type
  5. 4.2.1 Global Peripheral Coil Embolization System Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Peripheral Coil Embolization System Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Peripheral Coil Embolization System Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Peripheral Coil Embolization System Sales Value by Type
  9. 4.3.1 Global Peripheral Coil Embolization System Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Peripheral Coil Embolization System Sales Value by Type (2021-2032)
  11. 4.3.3 Global Peripheral Coil Embolization System Sales Value Share by Type (2021-2032)
5 Peripheral Coil Embolization System Market by Application
  1. 5.1 Peripheral Coil Embolization System Application Introduction
  2. 5.1.1 Arteriovenous Malformation
  3. 5.1.2 Arteriovenous Fistula
  4. 5.1.3 Other
  5. 5.2 Global Peripheral Coil Embolization System Sales Volume by Application
  6. 5.2.1 Global Peripheral Coil Embolization System Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Peripheral Coil Embolization System Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Peripheral Coil Embolization System Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Peripheral Coil Embolization System Sales Value by Application
  10. 5.3.1 Global Peripheral Coil Embolization System Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Peripheral Coil Embolization System Sales Value by Application (2021-2032)
  12. 5.3.3 Global Peripheral Coil Embolization System Sales Value Share by Application (2021-2032)
6 Peripheral Coil Embolization System Regional Sales and Value Analysis
  1. 6.1 Global Peripheral Coil Embolization System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Peripheral Coil Embolization System Sales by Region (2021-2032)
  3. 6.2.1 Global Peripheral Coil Embolization System Sales by Region: 2021-2026
  4. 6.2.2 Global Peripheral Coil Embolization System Sales by Region (2027-2032)
  5. 6.3 Global Peripheral Coil Embolization System Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Peripheral Coil Embolization System Sales Value by Region (2021-2032)
  7. 6.4.1 Global Peripheral Coil Embolization System Sales Value by Region: 2021-2026
  8. 6.4.2 Global Peripheral Coil Embolization System Sales Value by Region (2027-2032)
  9. 6.5 Global Peripheral Coil Embolization System Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Peripheral Coil Embolization System Sales Value (2021-2032)
  12. 6.6.2 North America Peripheral Coil Embolization System Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Peripheral Coil Embolization System Sales Value (2021-2032)
  15. 6.7.2 Europe Peripheral Coil Embolization System Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Peripheral Coil Embolization System Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Peripheral Coil Embolization System Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Peripheral Coil Embolization System Sales Value (2021-2032)
  21. 6.9.2 South America Peripheral Coil Embolization System Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Peripheral Coil Embolization System Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Peripheral Coil Embolization System Sales Value Share by Country, 2025 VS 2032
7 Peripheral Coil Embolization System Country-level Sales and Value Analysis
  1. 7.1 Global Peripheral Coil Embolization System Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Peripheral Coil Embolization System Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Peripheral Coil Embolization System Sales by Country (2021-2032)
  4. 7.3.1 Global Peripheral Coil Embolization System Sales by Country (2021-2026)
  5. 7.3.2 Global Peripheral Coil Embolization System Sales by Country (2027-2032)
  6. 7.4 Global Peripheral Coil Embolization System Sales Value by Country (2021-2032)
  7. 7.4.1 Global Peripheral Coil Embolization System Sales Value by Country (2021-2026)
  8. 7.4.2 Global Peripheral Coil Embolization System Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Peripheral Coil Embolization System Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Peripheral Coil Embolization System Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Peripheral Coil Embolization System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cook
  2. 8.1.1 Cook Company Information
  3. 8.1.2 Cook Business Overview
  4. 8.1.3 Cook Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cook Peripheral Coil Embolization System Product Portfolio
  6. 8.1.5 Cook Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Peripheral Coil Embolization System Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Kaneka
  14. 8.3.1 Kaneka Company Information
  15. 8.3.2 Kaneka Business Overview
  16. 8.3.3 Kaneka Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kaneka Peripheral Coil Embolization System Product Portfolio
  18. 8.3.5 Kaneka Recent Developments
  19. 8.4 Microvention
  20. 8.4.1 Microvention Company Information
  21. 8.4.2 Microvention Business Overview
  22. 8.4.3 Microvention Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Microvention Peripheral Coil Embolization System Product Portfolio
  24. 8.4.5 Microvention Recent Developments
  25. 8.5 Penumbra
  26. 8.5.1 Penumbra Company Information
  27. 8.5.2 Penumbra Business Overview
  28. 8.5.3 Penumbra Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Penumbra Peripheral Coil Embolization System Product Portfolio
  30. 8.5.5 Penumbra Recent Developments
  31. 8.6 Stryker
  32. 8.6.1 Stryker Company Information
  33. 8.6.2 Stryker Business Overview
  34. 8.6.3 Stryker Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Stryker Peripheral Coil Embolization System Product Portfolio
  36. 8.6.5 Stryker Recent Developments
  37. 8.7 Boston Scientific
  38. 8.7.1 Boston Scientific Company Information
  39. 8.7.2 Boston Scientific Business Overview
  40. 8.7.3 Boston Scientific Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Boston Scientific Peripheral Coil Embolization System Product Portfolio
  42. 8.7.5 Boston Scientific Recent Developments
  43. 8.8 Zylox-Tonbridge Medical Technology
  44. 8.8.1 Zylox-Tonbridge Medical Technology Company Information
  45. 8.8.2 Zylox-Tonbridge Medical Technology Business Overview
  46. 8.8.3 Zylox-Tonbridge Medical Technology Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zylox-Tonbridge Medical Technology Peripheral Coil Embolization System Product Portfolio
  48. 8.8.5 Zylox-Tonbridge Medical Technology Recent Developments
  49. 8.9 Genesis MedTech
  50. 8.9.1 Genesis MedTech Company Information
  51. 8.9.2 Genesis MedTech Business Overview
  52. 8.9.3 Genesis MedTech Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Genesis MedTech Peripheral Coil Embolization System Product Portfolio
  54. 8.9.5 Genesis MedTech Recent Developments
  55. 8.10 Conmind
  56. 8.10.1 Conmind Company Information
  57. 8.10.2 Conmind Business Overview
  58. 8.10.3 Conmind Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Conmind Peripheral Coil Embolization System Product Portfolio
  60. 8.10.5 Conmind Recent Developments
  61. 8.11 Medtronic
  62. 8.11.1 Medtronic Company Information
  63. 8.11.2 Medtronic Business Overview
  64. 8.11.3 Medtronic Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Medtronic Peripheral Coil Embolization System Product Portfolio
  66. 8.11.5 Medtronic Recent Developments
  67. 8.12 Peijia Medical
  68. 8.12.1 Peijia Medical Company Information
  69. 8.12.2 Peijia Medical Business Overview
  70. 8.12.3 Peijia Medical Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Peijia Medical Peripheral Coil Embolization System Product Portfolio
  72. 8.12.5 Peijia Medical Recent Developments
  73. 8.13 Shanghai Shenqi Medical Technology
  74. 8.13.1 Shanghai Shenqi Medical Technology Company Information
  75. 8.13.2 Shanghai Shenqi Medical Technology Business Overview
  76. 8.13.3 Shanghai Shenqi Medical Technology Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Shenqi Medical Technology Peripheral Coil Embolization System Product Portfolio
  78. 8.13.5 Shanghai Shenqi Medical Technology Recent Developments
  79. 8.14 Shanghai Xiaoyu Medical Technology
  80. 8.14.1 Shanghai Xiaoyu Medical Technology Company Information
  81. 8.14.2 Shanghai Xiaoyu Medical Technology Business Overview
  82. 8.14.3 Shanghai Xiaoyu Medical Technology Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Shanghai Xiaoyu Medical Technology Peripheral Coil Embolization System Product Portfolio
  84. 8.14.5 Shanghai Xiaoyu Medical Technology Recent Developments
  85. 8.15 Suzhou Zhongtian Medical Device Technology
  86. 8.15.1 Suzhou Zhongtian Medical Device Technology Company Information
  87. 8.15.2 Suzhou Zhongtian Medical Device Technology Business Overview
  88. 8.15.3 Suzhou Zhongtian Medical Device Technology Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Suzhou Zhongtian Medical Device Technology Peripheral Coil Embolization System Product Portfolio
  90. 8.15.5 Suzhou Zhongtian Medical Device Technology Recent Developments
  91. 8.16 Beijing Taijieweiye Technology
  92. 8.16.1 Beijing Taijieweiye Technology Company Information
  93. 8.16.2 Beijing Taijieweiye Technology Business Overview
  94. 8.16.3 Beijing Taijieweiye Technology Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Beijing Taijieweiye Technology Peripheral Coil Embolization System Product Portfolio
  96. 8.16.5 Beijing Taijieweiye Technology Recent Developments
  97. 8.17 MicroPort Scientific
  98. 8.17.1 MicroPort Scientific Company Information
  99. 8.17.2 MicroPort Scientific Business Overview
  100. 8.17.3 MicroPort Scientific Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 MicroPort Scientific Peripheral Coil Embolization System Product Portfolio
  102. 8.17.5 MicroPort Scientific Recent Developments
  103. 8.18 Shandong Visee Medical Devices
  104. 8.18.1 Shandong Visee Medical Devices Company Information
  105. 8.18.2 Shandong Visee Medical Devices Business Overview
  106. 8.18.3 Shandong Visee Medical Devices Peripheral Coil Embolization System Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Shandong Visee Medical Devices Peripheral Coil Embolization System Product Portfolio
  108. 8.18.5 Shandong Visee Medical Devices Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Peripheral Coil Embolization System Value Chain Analysis
  2. 9.1.1 Peripheral Coil Embolization System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Peripheral Coil Embolization System Sales Mode & Process
  6. 9.2 Peripheral Coil Embolization System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Peripheral Coil Embolization System Distributors
  9. 9.2.3 Peripheral Coil Embolization System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.